To characterize the disease course and visual outcome of uveitis in juvenile Behçet's disease (BD) compared with adults. The study population included 13 children (mean age 14±2.4 years; 22 eyes ...

Case Series Published: 07 April 2006 Adalimumab for sight-threatening uveitis in Behçet's disease B Mushtaq, T Saeed, R D Situnayake & P I Murray Eye 21, 824–825 (2007) Cite this article ...

Behçet's disease is an inflammatory disorder, with recurrent attacks of acute multisystem vasculitis. 1 Prevalence is highest among people of Middle Eastern or Far Eastern ancestry. Diagnosis of ...

Introduction Behçet's Disease (BD) is a systemic vasculitis with unique geographic distribution around the historical silk road. It is firstly defined as a disease causing recurrent oral and genital ...

Behcet's disease uveitis is characterized by relapse and remission in the course of the disease. The primary therapeutic objective of Behçet's disease uveitis is to control disease activity and ...

Adult patients with severe BD who met certain uveitis severity criteria were eligible for inclusion. Participants were randomly assigned in a 1:1:1 ratio to receive 1 of 3 treatments — cyclosporine (2 ...

3. Qian, Y ∙ Qu, Y ∙ Gao, F ∙ et al. Comparison of the safety and efficacy of interferon alpha-2a and cyclosporine-a when combined with glucocorticoid in the treatment of refractory behcet's uveitis: ...

Servier has received authorization to initiate a phase 3 clinical trial in several European countries to analyze the efficacy and safety of gevokizumab compared with placebo in reducing the risk ...

Self-reported general health was more impaired than visual function among patients with Behçet's uveitis, according to a study. "Several demographic and clinical variables had a significant ...

Uveitis is swelling of the middle layer of the eye, which provides blood to the retina. Read about causes, symptoms, and treatment.

This study aimed to replicate this finding in an independent cohort and to assess the specificity and sensitivity of NF-M immunoreactivity in serum samples obtained from BD, systemic lupus ...